Development of tumour selective and endoprotease-activated anticancer therapeutics.

Description

no

Links & Downloads

1. Gill, J. H. and Loadman, Paul M. (2008). Development of tumour selective and endoprotease-activated anticancer therapeutics. In: Edwards, D., Hoyer-Hansen, G., Blasi, F. and Sloane, B. F. (Eds.). The Cancer Degradome: Proteases and Cancer Biology. London: Springer. ISBN: 978-0-387-69056-8. Chapter 40.
2. http://hdl.handle.net/10454/4566
3. ISBN: 978-0-387-69056-8
4. https://doi.org/10.1007/978-0-387-69057-5

Tags

MMP

Prodrug

Anticancer therapeutics

Antitumor activity

Endoprotease

Additional Fields

Identifer	oai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/4566
Date	January 2008
Creators	Gill, Jason H., Loadman, Paul
Publisher	Springer
Source Sets	Bradford Scholars
Language	English
Detected Language	English
Type	Book chapter